Persbericht: Programma bekend van gebruikersevent GiLab Commit 2019
Amsterdam — 30 augustus 2019 — GitLab, het DevOps platform,... Lees verder →
Tag: Pharmaceuticals
UCB Completes the Acquisition of Ra Pharmaceuticals – to Deliver Differentiated Therapies to Patients
- The transaction, which was announced October 10, 2019, will enhance UCB's potential to be a leader in myasthenia gravis by adding zilucoplan, a peptide inhibitor of ...
Lees verder
Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New I
- Initiation of etrasimod Ph 2/3 program in Crohn's disease (CD) - Two additional Ph 2 etrasimod development programs in eosinophilic esophagitis (EoE) and alopecia areata ...
Lees verder
Centrient Pharmaceuticals: Kans om Wereldwijd Antibiotica Productieafval Aan te Pakken
ROTTERDAM, Nederland, 18 juni 2019 /PRNewswire/ -- Terwijl leiders samenkomen op de International Ministerial Conference over antimicrobiële resistentie (AMR), roepen ...
Lees verder
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park
LONDON, August 3, 2018 /PRNewswire/ -- Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet ...
Lees verder
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile
TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has successfully completed a Phase 1 multiple ...
Lees verder
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (Cannabidiol) Study in The Lancet
LONDON and CARLSBAD, California, January 24, 2018 /PRNewswire/ -- - First well-controlled clinical study of cannabidiol in Lennox-Gastaut syndrome, a rare, severe, form of ...
Lees verder
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
LONDON, December 29, 2017 /PRNewswire/ -- GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from ...
Lees verder
Foresee Pharmaceuticals Announces Results from Phase 1 Clinical Studies
Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-025, a Selective MMP-12 Inhibitor. TAIPEI, Taiwan, Dec. 4, 2017 /PRNewswire/ -- Foresee ...
Lees verder
Foresee Pharmaceuticals Announces CEO Appointment
TAIPEI, Taiwan, July 31, 2017 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today the appointment of Dr. Lawrence Gan to the position of ...
Lees verder
Debiopharm International SA and Arbor Pharmaceuticals, LLC Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the
LAUSANNE, Switzerland and ATLANTA, June 30, 2017 /PRNewswire/ -- Triptodur(TM), (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse ...
Lees verderNieuwe berichten
Persbericht: Nieuwe CEO voor Curvature
Curvature, een specialist in onafhankelijke IT-ondersteuning, producten en services,heeft een... Lees verder →
Persbericht: Valid bouwt datawarehouse met meetdata in Azure
Eindhoven, 29 augustus 2019 – Om goed te kunnen werken... Lees verder →
Persbericht: Sharp ontvangt ISO 27001-certificaat voor databeveiliging
Utrecht, 29 augustus 2019 – Sharp, leverancier van onderscheiden print-,... Lees verder →
